| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:14,15-Leukotriene D4
CAS:75290-64-1
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:14,15-Leukotriene D4
CAS:75290-64-1
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:14,15-Leukotriene D4
CAS:75290-64-1
Purity:97% Package:25μg;50μg;100μg
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:14,15-Leukotriene D4
CAS:75290-64-1
|
|
| | 14,15-LEUKOTRIENE D4 Basic information |
| Product Name: | 14,15-LEUKOTRIENE D4 | | Synonyms: | 14,15-LEUKOTRIENE D4;Eoxin D4;Glycine, S-[(1R,2E,4E,6Z,9Z)-13-carboxy-1-[(1S)-1-hydroxyhexyl]-2,4,6,9-tridecatetraen-1-yl]-L-cysteinyl- | | CAS: | 75290-64-1 | | MF: | C25H40N2O6S | | MW: | 496.66 | | EINECS: | | | Product Categories: | | | Mol File: | 75290-64-1.mol |  |
| | 14,15-LEUKOTRIENE D4 Chemical Properties |
| Boiling point | 786.4±60.0 °C(Predicted) | | density | 1.162±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 1 mg/ml; PBS (pH 7.2): >100 μg/ml | | pka | 3.03±0.10(Predicted) |
| | 14,15-LEUKOTRIENE D4 Usage And Synthesis |
| Description | 14,15-Leukotriene D4 (14,15-LTD4) is a member of an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-lipoxygenases (15- and 12-LOs) on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates. 14,15-LTD4 is classified as an eoxin (EXD4), because it is formed mostly by eosinophils. However, mast cells and nasal polyps can synthesize 14,15-LTD4 as well. Little is known about the physiological actions of 14,15-LTD4. It has weak contractile activity on both guinea pig ileum and pulmonary parenchyma in contrast to the effects of 5-LO-derived LTs. However, in an in vitro permeability assay, 14,15-LTD4 can increase vascular permeability of human endothelial cell monolayers, with similar potency to that of 5-LO-derived LTs, resulting in plasma leakage, a hallmark of inflammation. | | Uses | Eoxin D4 is synthesized via the 15-lipoxygenase-1 pathway in human eosinophils. Eoxins are proinflammatory arachidonic acid metabolites produced by mast cells. | | Definition | ChEBI: Eoxin D4 is a leukotriene that is the 14R-(S-cysteinylglycyl),15S-hydroxy derivative of (5Z,8Z,10E,12E)-icosa-7,9,11,14-tetraenoic acid. It has a role as a metabolite. It is a leukotriene and an eoxin. It is functionally related to a (5Z,8Z,10E,12E)-icosatetraenoic acid. |
| | 14,15-LEUKOTRIENE D4 Preparation Products And Raw materials |
|